TRVI
Trevi Therapeutics, Inc.
+0.14 (+0.97%)15.16USD597K成交股數2.2B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 15.2M | 9.9M | 6.2M | 10.1M | 9.4M | 7.8M | 11.2M | 10.0M | 8.8M | 6.5M | 6.3M | 5.8M |
| 銷售管理費用 | 5.4M | 5.0M | 4.0M | 3.8M | 4.3M | 3.7M | 2.9M | 3.3M | 3.1M | 2.4M | 2.7M | 2.5M |
| 營業利益 | −20.5M+49% | −14.9M+30% | −10.2M-27% | −13.9M+5% | −13.7M+15% | −11.5M+28% | −14.1M+56% | −13.3M+59% | −11.9M | −8.9M | −9.0M | −8.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −17.8M+45% | −13.2M+28% | −8.3M-37% | −11.8M-4% | −12.3M+13% | −10.3M+32% | −13.2M+72% | −12.4M+73% | −10.9M | −7.8M | −7.7M | −7.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.11+22% | -0.090% | -0.06-54% | -0.08-33% | -0.09-18% | -0.09+13% | -0.13+63% | -0.12+71% | -0.11 | -0.08 | -0.08 | -0.07 |
| 稀釋股數 | 157M | 146M | 135M | 145M | 130M | 118M | 101M | 101M | 99.5M | 99.0M | 99.3M | 98.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 54.3M | 19.4M | 18.9M | 56.9M | 117M | 19.4M | 16.1M | 13.0M | 13.8M | 32.4M | 26.0M | 13.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 331M | 180M | 193M | 199M | 208M | 107M | 68.9M | 73.8M | 78.6M | 89.4M | 95.9M | 101M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 9.0M | 7.5M | 10.2M | 9.6M | 9.8M | 7.5M | 9.9M | 7.6M | 6.2M | 6.9M | 6.3M | 5.9M |
| 股東權益 | 322M | 172M | 183M | 190M | 198M | 99.5M | 59.0M | 66.2M | 72.3M | 82.5M | 89.6M | 95.1M |
| 負債比 | 2.7% | 4.2% | 5.3% | 4.8% | 4.7% | 7.1% | 14.4% | 10.3% | 7.9% | 7.7% | 6.6% | 5.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −16.7M+24% | – | – | – | −13.5M | – | – | −10.5M | – | – | – |
| 資本支出 | – | 102K | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | −16.8M | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 34K | – | – | – | 37K | – | – | 35K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −42.8M | –% | -0.32 | −42.1M |
| FY2024 | – | – | −47.9M | –% | -0.47 | −38.3M |
| FY2023 | – | – | −29.1M | –% | -0.29 | −31.8M |
| FY2022 | – | – | −29.2M | –% | -0.45 | −28.3M |
| FY2021 | – | – | −33.9M | –% | -1.49 | – |
| FY2020 | – | – | −32.8M | –% | -1.81 | −29.0M |
| FY2019 | – | – | −26.1M | –% | -2.28 | −23.1M |
| FY2018 | – | – | −20.5M | –% | -58.44 | −18.4M |